{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Terns Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"TERN"},"Address":{"label":"Address","value":"1065 EAST HILLSDALE BOULEVARD,SUITE 100, FOSTER, California, 94404, United States"},"Phone":{"label":"Phone","value":"+1 650 525-5535"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.ternspharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Amy L. Burroughs","title":"Chief Executive Officer & Director"},{"name":"Bryan Yoon","title":"COO, Secretary & General Counsel"},{"name":"Jeffrey R. Jasper","title":"Senior Vice President & Head-Research"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}